CDTX - Cidara Therapeutics GAAP EPS of -$0.14 misses by $0.01 revenue of $7.61M misses by $3.94M
2023-08-03 17:37:53 ET
- Cidara Therapeutics press release ( NASDAQ: CDTX ): Q2 GAAP EPS of -$0.14 misses by $0.01 .
- Revenue of $7.61M (+22.3% Y/Y) misses by $3.94M .
- Shares -2.11% AH.
For further details see:
Cidara Therapeutics GAAP EPS of -$0.14 misses by $0.01, revenue of $7.61M misses by $3.94M